CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma

FHS
July 11, 2024
7:40 pm

CAR-T cell therapy, which targets a specific protein on the surface of cancer cells, causes tumors to shrink or disappear in about half of patients with large B-cell lymphoma who haven’t experienced improvement with chemotherapy treatments.

Conestat alfa by Pharming Group for Acute Ischemic Stroke: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

May 17, 2024

Nixing the X Waiver Hasn’t Yet Vastly Expanded Buprenorphine Access

While the elimination of the X waiver increased the number of clinicians prescribing buprenorphine, it hasn’t yet had a substantial impact on the number of

April 25, 2024

Opinion | For Health AI to Fulfill Its Potential, Regulation Is Paramount

Brown is an emergency medicine physician and business expert. Shah is a physician and health AI company executive. Artificial Intelligence (AI) has been used in

November 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.